L
NYSE · Financial Services · Insurance - Property & Casualty · US
Next report
Analyst consensus
- Next report date
- Nov 2, 2026
- EPS estimate
- —
- Revenue estimate
- —
Latest reported
- Last report date
- Jul 30, 2026
- EPS actual
- $2.16
- EPS estimate
- —
- Revenue actual
- $4.7B
- Revenue estimate
- —
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 3
- EPS misses (12Q)
- 1
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- +25.7%
- Revenue beats (12Q)
- 1
Q4 FY2024 · Feb 20, 2025
AI summary of management’s prepared remarks and analyst Q&A · For informational purposes only, not investment advice
Management highlights
Management Statement and Operational Highlights
- Retail Excellence Focus: Maintained focus on quality, value, service, and convenience. Delivered revenue growth and adjusted earnings. Repurchased shares and increased dividend.
- Store Expansion: Opened 52 new food and drug retail stores and 78 pharmacy care clinics in 2024. Plan to open 80 stores and 100 pharmacist care clinics in 2025.
- Digital Growth: Online sales increased by 18.4% in the quarter. PC Optimum program liability revalued due to higher redemption rates.
- ESG Initiatives: Early release of 2024 ESG disclosures, focus on social equity and climate change.
Guidance
Guidance
- 2025 Plans: Plan to open approximately 50 hard discount stores, 30 Shoppers Drug Mart, and 2 TNT stores. Estimate incremental impact on EPS of approximately 2% from an extra week in 2025. Expect retail business to grow earnings faster than sales with adjusted earnings per share growth in the high single digits.
- Capital Expenditures: Plan to invest approximately $2.2 billion in capital expenditures and $1.9 billion net of proceeds from property disposal.
Segment performance
Segment Performance
- Food Retail: Absolute sales grew 3.7%, reported same-store sales increased 2.5%, adjusted same-store sales growth was up 2% in the quarter. Contributed significantly to overall revenue.
- Drug Retail: Absolute sales increased 1.3% and same-store sales grew 1.3%. Pharmacy and healthcare services grew same-store sales by 6.3%. Front store same-store sales declined 3.1% due to Canada Post strike and exit of electronics categories.
- PC Financial: Revenue decreased 2.3%, but adjusted earnings before tax increased by $20 million due to higher interchange and credit card fee income, lower operating costs, and positive ECL provisions.
Risks & headwinds
Risks
- Inflation Pressures: Higher than normal pricing increases from global vendors, Canadian dollar weakness impacting US imports, potential tariffs on imports.
- Competitive Environment: Impact of competitors entering territories, potential drag on gross margins from new store openings and DC ramp-up.
Analyst Q&A
Question and Answer
Q: Discuss momentum drivers and share of customer wallet A: Driven by new stores, delayed cough and cold sales benefits, and market share gains. PC Optimum and store harmonization initiatives contributing.
Q: Impact of new stores and DC on financial results A: Quantified impact incorporated in guidance, DC ramp-up on plan, new stores expected to provide long-term tailwind.
Q: Tariff exposure and sourcing A: Less than 10% of COGS from US, mostly in produce; working to mitigate impact, control brands help with tariffs.
Q: Small format stores and consumer response A: Small formats like No Frills perform well, customers can do full shops, sales increasing weekly.
Q: Retail media business and EPS growth A: Retail media and trade as a service business expected to grow double-digit, EPS growth expected to be steady with slight gross margin increase.
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 2, 2026